Venous access and care: Harnessing pragmatics in harm reduction for people who inject drugs

Addiction

Volumn 107, Issue 6, 2012, Pages 1090-1096

  Harris, Magdalena ^a   Rhodes, Tim ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Harm reduction; Hepatitis C; Injecting drug use; Prevention; Vein care

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; DISEASE TRANSMISSION; FEMALE; HARM REDUCTION; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SCLEROSIS; SUBSTANCE ABUSE; VEIN;

ADULT; ATTITUDE TO HEALTH; FEMALE; HARM REDUCTION; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; SCLEROSIS; SUBSTANCE ABUSE, INTRAVENOUS; VEINS; YOUNG ADULT;

EID: 84860551989     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03749.x     Document Type: Article

References (32)

1. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction 2010; 105: 844-59.
2. Health Protection Agency. Hepatitis C in the UK 2009. London: Health Protection Agency Centre for Infections; 2009.
3. National Centre in HIV Epidemiology and Clinical Research. Australian NSP survey national data report 2004-2008. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW; 2009. Available at: (Archived by WebCite® at ) (accessed 12 March 2011).
4. De P., Roy Ã., Boivin J. F., Cox J., Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepatol 2008; 15: 279-92.
5. Mathers B. M., Degenhardt L., Ali H., Wiessing L., Hickman M., Mattick R. P. etal. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010; 375: 1014-28.
6. Maher L., Li J., Jalaludin B., Chant K., Kaldor J. High hepatitis C incidence in new injecting drug users: a policy failure? Aust NZ J Public Health 2007; 31: 30-5.
7. Vickerman P., Hickman M., Judd A. Modelling the impact on hepatitis C transmission of reducing syringe sharing: London case study. Int J Epidemiol 2007; 36: 396-405.
8. Treloar C., Fraser S. Hepatitis C, blood and models of the body: new directions for public health. Crit Public Health 2004; 14: 377-89.
9. Garfein R., Golub E., Greenberg A., Hagan H., Hanson D., Hudson S. etal. A peer-education intervention to reduce injection risk behaviours for HIV and hepatitis C virus infection in young injection drug users. AIDS 2007; 21: 1923-32.
10. Gresbach D., Taylor A. Educational Interventions to Prevent Hepatitis C: A Review of the Literature and Expert Opinion. Glasgow: NHS Health Scotland; 2009.
11. Rhodes T., Treloar C. The social production of hepatitis C risk among injecting drug users: a qualitative synthesis. Addiction 2008; 103: 1593-603.
12. Rhodes T., Coomber R. Qualitative methods and theory in addictions research. In: Miller P. G., Strang J., Miller P. M., editors. Addiction Research Methods. Oxford, UK: Wiley-Blackwell; 2010, p. 59-78.
13. Davis M., Rhodes T., Martin A. Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs. Soc Sci Med 2004; 59: 1807-18.
14. Harris M. Troubling biographical disruption: narratives of unconcern about hepatitis C diagnosis. Soc Health Illn 2009; 31: 1028-45.
15. Wozniak L., Prakash M., Taylor M., Wild T. C. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada. Int J Drug Policy 2007; 18: 388-96.
16. Davis M., Rhodes T. Beyond prevention? Injecting drug user narratives about hepatitis C. Int J Drug Policy 2004; 15: 123-31.
17. Stockman J. K., Schwarcz S. K., Butler L. M., de Jong B., Chen S. Y., Delgado V. etal. HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr 2004; 35: 432-4.
18. Roy K., Hay G., Andragetti R., Taylor A., Goldberg D., Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect 2002; 129: 577-85.
19. Kirst M. J. Social capital and beyond: a qualitative analysis of social contextual and structural influences on drug-use related health behaviors. J Drug Issues 2009; 39: 653-76.
20. Fraser S. 'It's your life!': injecting drug users, individual responsibility and hepatitis C prevention. Health (Lond) 2004; 8: 199-221.
21. Aggleton P., Jenkins P., Malcolm A. HIV/AIDS and injecting drug use: information, education and communication. Int J Drug Policy 2005; 16: 21-30.
22. Friedman S., Mateu-Gelabert P., Sandoval M., Hagan H., Des Jarlais D. Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection. BMC Public Health 2008; 8: 1-10.
23. Harris M., Treloar C., Maher L. Staying safe from hepatitis C: engaging with multiple priorities. Qual Health Res 2012; 22: 21-42.
24. Glaser B. G., Strauss A. L. The Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago, IL: Aldine; 1967.
25. Riessman C. K. Strategic uses of narrative in the presentation of self and illness: a research note. Soc Sci Med 1990; 30: 1195-200.
26. Rhodes T., Briggs D., Kimber J., Jones S., Holloway G. Crack-heroin speedball injection and its implications for vein care: qualitative study. Addiction 2007; 102: 1782-90.
27. Strang J., Keaney F., Butterworth G., Noble A., Best D. Different forms of heroin and their relationship to cook-up techniques: data on, and explanation of, use of lemon juice and other acids. Subst Use Misuse 2001; 36: 573-88.
28. Maliphant J., Scott J. Use of the femoral vein ('groin injecting') by a sample of needle exchange clients in Bristol, UK. Harm Reduct J 2005; 2: 1-6.
29. Ciccarone D., Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse 2003; 38: 2049-63.
30. Race K. The use of pleasure in harm reduction: perspectives from the history of sexuality. Int J Drug Policy 2008; 19: 417-23.
31. Philpott A., Knerr W., Boydell V. Pleasure and prevention: when good sex is safer sex. Reprod Health Matters 2006; 14: 23-31.
32. Semer N., Ellison J., Mansell C., Hoika L., MacDougall W., Gansky S. A. etal. Development and evaluation of a tobacco cessation motivational program for adolescents based on physical attractiveness and oral health. J Dent Hyg 2005; 79: 9.